We reasoned that HIF-1α might underlie this differential response of low-AR and high-AR prostate cancer cells due to its interaction with AR to form a ternary complex with β-catenin that is required for hypoxia-activated AR transactivation [57]. This evidence concerns the gene HIF1A and prostate carcinoma.